Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age
(2010) BONE. 46(4). p.1038-1042
Please use this url to cite or link to this publication:
http://hdl.handle.net/1854/LU-1194250
- author
- Ego Seeman, Steven Boonen, Frederik Borgstrom, Bruno Vellas, Jean-Pierre Aquino, Jutta Semler, Claude-Laurent Benhamou, Jean Kaufman UGent and Jean-Yves Reginster
- organization
- year
- 2010
- type
- journalArticle (original)
- publication status
- published
- subject
- keyword
- BONE-MINERAL DENSITY, RANDOMIZED CLINICAL-TRIAL, LONG-TERM COMPLICATION, POSTMENOPAUSAL OSTEOPOROSIS, BISPHOSPHONATE TREATMENT, HIP FRACTURE, ALENDRONATE THERAPY, ANTIRESORPTIVE AGENTS, COST-EFFECTIVENESS, Clinical trial, ZOLEDRONIC ACID, Strontium Ranelate, Elderly population, Antiosteoporotic treatment, Osteoporosis, Osteoporotic fracture
- journal title
- BONE
- Bone
- volume
- 46
- issue
- 4
- pages
- 1038 - 1042
- Web of Science type
- Article
- Web of Science id
- 000276009400024
- JCR category
- ENDOCRINOLOGY & METABOLISM
- JCR impact factor
- 4.601 (2010)
- JCR rank
- 26/115 (2010)
- JCR quartile
- 1 (2010)
- ISSN
- 8756-3282
- DOI
- 10.1016/j.bone.2009.12.006
- language
- English
- UGent publication?
- yes
- classification
- A1
- copyright statement
- I have transferred the copyright for this publication to the publisher
- id
- 1194250
- handle
- http://hdl.handle.net/1854/LU-1194250
- date created
- 2011-03-22 14:26:53
- date last changed
- 2016-12-19 15:45:50
@article{1194250,
author = {Seeman, Ego and Boonen, Steven and Borgstrom, Frederik and Vellas, Bruno and Aquino, Jean-Pierre and Semler, Jutta and Benhamou, Claude-Laurent and Kaufman, Jean and Reginster, Jean-Yves},
issn = {8756-3282},
journal = {BONE},
keyword = {BONE-MINERAL DENSITY,RANDOMIZED CLINICAL-TRIAL,LONG-TERM COMPLICATION,POSTMENOPAUSAL OSTEOPOROSIS,BISPHOSPHONATE TREATMENT,HIP FRACTURE,ALENDRONATE THERAPY,ANTIRESORPTIVE AGENTS,COST-EFFECTIVENESS,Clinical trial,ZOLEDRONIC ACID,Strontium Ranelate,Elderly population,Antiosteoporotic treatment,Osteoporosis,Osteoporotic fracture},
language = {eng},
number = {4},
pages = {1038--1042},
title = {Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age},
url = {http://dx.doi.org/10.1016/j.bone.2009.12.006},
volume = {46},
year = {2010},
}
- Chicago
- Seeman, Ego, Steven Boonen, Frederik Borgstrom, Bruno Vellas, Jean-Pierre Aquino, Jutta Semler, Claude-Laurent Benhamou, Jean Kaufman, and Jean-Yves Reginster. 2010. “Five Years Treatment with Strontium Ranelate Reduces Vertebral and Nonvertebral Fractures and Increases the Number and Quality of Remaining Life-years in Women over 80 Years of Age.” Bone 46 (4): 1038–1042.
- APA
- Seeman, E., Boonen, S., Borgstrom, F., Vellas, B., Aquino, J.-P., Semler, J., Benhamou, C.-L., et al. (2010). Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. BONE, 46(4), 1038–1042.
- Vancouver
- 1.Seeman E, Boonen S, Borgstrom F, Vellas B, Aquino J-P, Semler J, et al. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. BONE. 2010;46(4):1038–42.
- MLA
- Seeman, Ego, Steven Boonen, Frederik Borgstrom, et al. “Five Years Treatment with Strontium Ranelate Reduces Vertebral and Nonvertebral Fractures and Increases the Number and Quality of Remaining Life-years in Women over 80 Years of Age.” BONE 46.4 (2010): 1038–1042. Print.